ARIX BIOSCIENCE

arix-bioscience-logo

Arix Bioscience is a global venture capital firm that invests in biotechnology firms. It works with exceptional entrepreneurs and provides the capital, expertise, and global networks required to help them turn their ideas into significant new treatments for patients. As a publicly traded company, they can bring this exciting growth phase of the industry to a wider range of investors.

#SimilarOrganizations #People #Financial #Website #More

ARIX BIOSCIENCE

Social Links:

Industry:
Biotechnology Finance Health Care Venture Capital

Founded:
2015-09-15

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.arixbioscience.com

Total Employee:
251+

Status:
Active

Contact:
44 (0)20 7290 1050

Email Addresses:
[email protected]

Total Funding:
21.44 M USD

Technology used in webpage:
HSTS Nginx Facebook Sharer GoDaddy SSL Invalid Certificate Dates Nginx 1.17


Similar Organizations

cormco-logo

CORMCO

CORMCO ® is a global holding company founded in 1998. Its subsidiaries include Corm Capital (investments) and OX Factory.

eurekare-logo

eureKARE

eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

healthpath-logo

Healthpath

Healthpath provides Wellness and Fitness Services.

iamfire-logo

IamFire

IamFire is an investment firm that invests in a range of sectors like natural resource, life science and biotechnology.

invivo-capital-partners-logo

Invivo Capital Partners

Invivo is focused on investing in early-stage companies in Healthcare sector: biotech, medical devices and e-Health.

kbp-biosciences-logo

KBP Biosciences

A multinational clinical stage biotechnology company.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

christian-schetter_image

Christian Schetter
Christian Schetter Managing Director @ Arix Bioscience
Managing Director
2020-06-01

joe-anderson_image

Joe Anderson
Joe Anderson Chief Investment Officer @ Arix Bioscience
Chief Investment Officer
2018-09-01

jonathan-tobin_image

Jonathan Tobin
Jonathan Tobin Managing Director @ Arix Bioscience
Managing Director
2016-07-01

daniel-oconnell_image

Daniel O'Connell
Daniel O'Connell Investment Manager @ Arix Bioscience
Investment Manager
2016-10-01

angela-ene_image

Angela Ene
Angela Ene Interim Finance Director @ Arix Bioscience
Interim Finance Director

james-rawlingson_image

James Rawlingson
James Rawlingson Chief Financial Officer @ Arix Bioscience
Chief Financial Officer
2016-01-01

mark-chin_image

Mark Chin
Mark Chin Investment Manager @ Arix Bioscience
Investment Manager

robert-lyne_image

Robert Lyne
Robert Lyne Chief Executive Officer @ Arix Bioscience
Chief Executive Officer
2021-10-01

trevor-jones_image

Trevor Jones
Trevor Jones Director @ Arix Bioscience
Director
2016-02-01

mark-chin_image

Mark Chin
Mark Chin Investment Director @ Arix Bioscience
Investment Director
2016-01-01

Founder


robert-lyne_image

Robert Lyne

Stock Details


Company's stock symbol is LSE:ARIX

Investments List

Date Company Article Money raised
2023-04-26 Evommune Arix Bioscience investment in Series B - Evommune 50 M USD
2023-03-27 Harpoon Therapeutics Arix Bioscience investment in Post-IPO Equity - Harpoon Therapeutics 25 M USD
2023-01-05 Ensoma Arix Bioscience investment in Series B - Ensoma 85 M USD
2022-08-10 Disc Medicine Arix Bioscience investment in Post-IPO Equity - Disc Medicine 53.5 M USD
2021-12-22 Sorriso Pharmaceuticals Arix Bioscience investment in Series A - Sorriso Pharmaceuticals 31 M USD
2021-12-15 Depixus Arix Bioscience investment in Series A - Depixus 30.6 M EUR
2021-09-02 Disc Medicine Arix Bioscience investment in Post-IPO Equity - Disc Medicine 90 M USD
2021-07-27 Artios Pharma Arix Bioscience investment in Series C - Artios Pharma 110 M GBP
2021-03-30 Pyxis Oncology Arix Bioscience investment in Series B - Pyxis Oncology 152 M USD
2021-03-22 Aura Biosciences Arix Bioscience investment in Venture Round - Aura Biosciences 80 M USD

Official Site Inspections

http://www.arixbioscience.com

  • Host name: 68.183.255.50
  • IP address: 68.183.255.50
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...

More informations about "Arix Bioscience"

Investing in and building breakthrough biotech …

Apr 26, 2023 Unconstrained by institution, geography or stage of company development; we have the ability to source the best life science innovation without restriction. We partner with the most ambitious entrepreneurs to build …See details»

Arix Bioscience - Crunchbase Company Profile & Funding

Organization. Arix Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact …See details»

Arix Bioscience - Overview, News & Similar companies - ZoomInfo

Jul 30, 2023 Arix Bioscience contact info: Phone number: (646) 357-3700 Website: www.arixbioscience.com What does Arix Bioscience do? Arix Bioscience plc is a venture …See details»

Arix Bioscience (Group) - Life-Sciences-Europe.com

Feb 2, 2017 https://www.arixbioscience.com Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and …See details»

RTW Biotech to acquire Arix Bioscience's assets

Nov 1, 2023 [email protected] Jefferies (Financial Adviser & Joint Corporate Broker to Arix) +44 20 7029 8000. Philip Yates. Simon Hardy. Lee Morton Shaam Vora Powerscourt …See details»

Arix Bioscience investment portfolio | PitchBook

Arix Bioscience General Information Company Description. Founded in 2016, Arix Bioscience is a venture capital firm based in London, United Kingdom. The firm prefers to invest in seed-stage …See details»

Company Arix Bioscience plc Deutsche Boerse AG

Apr 28, 2021 Arix Bioscience plc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG: 3HY ...See details»

IN BRIEF: Arix Bioscience shares suspended ahead of ... - Morningstar

Feb 12, 2024 Arix Bioscience PLC - London-based venture capital firm focused on biotechnology companies - ...See details»

Arix Bioscience Plc Company Profile - Overview - GlobalData

Website arixbioscience.com Telephone 44 20 72901050. No of Employees 7. Industry Financial Services. Revenue (2022) $138,100 Gain access to our ...See details»

Arix Bioscience PLC: Arix Bioscience co-leads $31 ... - Markets Insider

Dec 22, 2021 Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals . Arix announces a new portfolio company, Sorriso, with a 26% …See details»

RECOMMENDED ALL-SHARE ACQUISITION OF THE ASSETS OF …

Jan 30, 2024 Results of First General Meeting. On 1 November 2023, the boards of RTW Bio and Arix announced (the "Original Announcement") that they had agreed to the terms of a …See details»

Arix Bioscience, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Arix Bioscience, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Arix Announces Strategic Review | Markets Insider

Jul 13, 2023 ir @arixbioscience.com . Powerscourt Group. Sarah MacLeod, Ibrahim Khalil, Nick Johnson +44 (0)20 7250 1446. [email protected] . About Arix Bioscience plc.See details»

Arix Co-leads $50 Million Series B Financing for New Portfolio …

Apr 27, 2023 Arix co-led the $50 million round for Evommune, a clinical-stage biotechnology company discovering and developing new ways to treat inflammatory diseases, investing $8.1 …See details»

Arix leads USD152 million Series B financing for Pyxis Oncology

Mar 30, 2021 [ENDS] For more information on Arix, please contact: Arix Bioscience plc Charlotte Parry, Head of Investor Relations +44 (0)20 7290 1072 [email protected] …See details»

Results of First General Meeting | Markets Insider

Jan 29, 2024 Arix Bioscience PLC (ARIX) Results of First General Meeting 29-Jan-2024 / 12:15 GMT/BSTSee details»

Arix Bioscience (ARIX) Share Price, News & Analysis - MarketBeat

Nov 23, 2024 Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, …See details»

What is Arix Bioscience? Company Culture, Mission, Values

See what employees say it's like to work at Arix Bioscience. Salaries, reviews, and more - all posted by employees working at Arix Bioscience.See details»

Update on the Scheme and Resignation of Directors

Jan 22, 2024 [email protected] . Jefferies (Financial Adviser & Corporate Broker to Arix) +44 20 7029 8000. Philip Yates. Simon Hardy . Shaam Vora . Powerscourt Group (PR & …See details»

Working at Arix Bioscience - Glassdoor

See what employees say it's like to work at Arix Bioscience. Salaries, reviews, and more - all posted by employees working at Arix Bioscience.See details»

linkstock.net © 2022. All rights reserved